|2. Delay the start of biologic to administer live attenuated vaccines over starting the biologic and administering live attenuated vaccines (PICO 57)|Very low (127)|
|Conditional recommendation based on very-low-quality evidence; may consider starting the biologic and administering live attenuated vaccines in patients with very active severe joint§ or skin¶ disease who prefer no delay in biologic initiation.| |</p>